Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Early detection and tailored treatment of lupus nephritis are crucial to prevent kidney damage.

Electrical stimulation with a low-calorie diet reduces appetite, weight, and blood pressure in obese people with sleep apnea.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Correcting nutrient deficiencies may help with hair loss, but the benefits of supplements without a deficiency are uncertain and could be harmful.

Neurosteroids show promise for treating epilepsy and more research is needed.

Tooth regeneration could become possible by controlling how and when bioactive factors are released.

Pannexin 3 is important for bone formation and the development of bone cells.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Scientists have made progress in growing mini-organs and regenerating parts of the skin, with plans to treat hair loss in a future trial.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

RoPod helps study plant root cell changes and autophagy with minimal stress.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

The lecture concluded that drugs for human enhancement are here to stay and called for their responsible development and fair access.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

The document concludes that advancements in hair restoration surgery have led to more natural results and patient satisfaction, with hope for future improvements in treatment.

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.